調査レポート | • レポートコード：GIR-2104Z02677 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん検査の種類別市場規模（臨床検査、遺伝子検査、画像診断、内視鏡検査）、用途別市場規模（膀胱がん検査、乳がん検査、子宮頸がん検査、結腸直腸（結腸）がん検査、卵巣がん検査、前立腺がん検査、肝がん検査、フローサイトメトリー、その他臓器特異的がん検査）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Radient Pharmaceuticals、BD Diagnostics、Beckman Coulter、BioCurex、bioMerieux、Cepheid、CytoCore、DiagnoCure、Gen-Probe、Genomic Health、QIAGEN Marseille (Earlier Ipsogen)、Myriad Genetics、Panacea Pharmaceuticals、Qiagen、Siemens Heathcare Diagnostics、Roche、Roche(Ventana Medical Systems)、Trovagene、Vermillion ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：臨床検査、遺伝子検査、画像診断、内視鏡検査 ・用途別分析2016年-2026年：膀胱がん検査、乳がん検査、子宮頸がん検査、結腸直腸（結腸）がん検査、卵巣がん検査、前立腺がん検査、肝がん検査、フローサイトメトリー、その他臓器特異的がん検査 ・がん検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cancer Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Test size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Cancer Test market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cancer Test market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Market segment by Application, can be divided into
Bladder Cancer Test
Breast Cancer Test
Cervical Cancer Test
Colorectal (Colon) Cancer Test
Ovarian Cancer Test
Prostate Cancer Test
Liver Cancer Test
Flow Cytometry
Other Organ Specific Cancer Test
Market segment by players, this report covers
Abbott
Radient Pharmaceuticals
BD Diagnostics
Beckman Coulter
BioCurex
bioMerieux
Cepheid
CytoCore
DiagnoCure
Gen-Probe
Genomic Health
QIAGEN Marseille (Earlier Ipsogen)
Myriad Genetics
Panacea Pharmaceuticals
Qiagen
Siemens Heathcare Diagnostics
Roche
Roche(Ventana Medical Systems)
Trovagene
Vermillion
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cancer Test
1.2 Classification of Cancer Test by Type
1.2.1 Overview: Global Cancer Test Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Test Revenue Market Share by Type in 2020
1.2.3 Laboratory Tests
1.2.4 Genetic Tests
1.2.5 Imaging
1.2.6 Endoscopy
1.3 Global Cancer Test Market by Application
1.3.1 Overview: Global Cancer Test Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Bladder Cancer Test
1.3.3 Breast Cancer Test
1.3.4 Cervical Cancer Test
1.3.5 Colorectal (Colon) Cancer Test
1.3.6 Ovarian Cancer Test
1.3.7 Prostate Cancer Test
1.3.8 Liver Cancer Test
1.3.9 Flow Cytometry
1.3.10 Other Organ Specific Cancer Test
1.4 Global Cancer Test Market Size & Forecast
1.5 Global Cancer Test Market Size and Forecast by Region
1.5.1 Global Cancer Test Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Test Market Size by Region, (2016-2021)
1.5.3 North America Cancer Test Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Test Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Test Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Test Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Test Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Test Market Drivers
1.6.2 Cancer Test Market Restraints
1.6.3 Cancer Test Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Cancer Test Product and Solutions
2.1.4 Abbott Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Radient Pharmaceuticals
2.2.1 Radient Pharmaceuticals Details
2.2.2 Radient Pharmaceuticals Major Business
2.2.3 Radient Pharmaceuticals Cancer Test Product and Solutions
2.2.4 Radient Pharmaceuticals Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Radient Pharmaceuticals Recent Developments and Future Plans
2.3 BD Diagnostics
2.3.1 BD Diagnostics Details
2.3.2 BD Diagnostics Major Business
2.3.3 BD Diagnostics Cancer Test Product and Solutions
2.3.4 BD Diagnostics Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 BD Diagnostics Recent Developments and Future Plans
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business
2.4.3 Beckman Coulter Cancer Test Product and Solutions
2.4.4 Beckman Coulter Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beckman Coulter Recent Developments and Future Plans
2.5 BioCurex
2.5.1 BioCurex Details
2.5.2 BioCurex Major Business
2.5.3 BioCurex Cancer Test Product and Solutions
2.5.4 BioCurex Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 BioCurex Recent Developments and Future Plans
2.6 bioMerieux
2.6.1 bioMerieux Details
2.6.2 bioMerieux Major Business
2.6.3 bioMerieux Cancer Test Product and Solutions
2.6.4 bioMerieux Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 bioMerieux Recent Developments and Future Plans
2.7 Cepheid
2.7.1 Cepheid Details
2.7.2 Cepheid Major Business
2.7.3 Cepheid Cancer Test Product and Solutions
2.7.4 Cepheid Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cepheid Recent Developments and Future Plans
2.8 CytoCore
2.8.1 CytoCore Details
2.8.2 CytoCore Major Business
2.8.3 CytoCore Cancer Test Product and Solutions
2.8.4 CytoCore Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 CytoCore Recent Developments and Future Plans
2.9 DiagnoCure
2.9.1 DiagnoCure Details
2.9.2 DiagnoCure Major Business
2.9.3 DiagnoCure Cancer Test Product and Solutions
2.9.4 DiagnoCure Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 DiagnoCure Recent Developments and Future Plans
2.10 Gen-Probe
2.10.1 Gen-Probe Details
2.10.2 Gen-Probe Major Business
2.10.3 Gen-Probe Cancer Test Product and Solutions
2.10.4 Gen-Probe Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Gen-Probe Recent Developments and Future Plans
2.11 Genomic Health
2.11.1 Genomic Health Details
2.11.2 Genomic Health Major Business
2.11.3 Genomic Health Cancer Test Product and Solutions
2.11.4 Genomic Health Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Genomic Health Recent Developments and Future Plans
2.12 QIAGEN Marseille (Earlier Ipsogen)
2.12.1 QIAGEN Marseille (Earlier Ipsogen) Details
2.12.2 QIAGEN Marseille (Earlier Ipsogen) Major Business
2.12.3 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Product and Solutions
2.12.4 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 QIAGEN Marseille (Earlier Ipsogen) Recent Developments and Future Plans
2.13 Myriad Genetics
2.13.1 Myriad Genetics Details
2.13.2 Myriad Genetics Major Business
2.13.3 Myriad Genetics Cancer Test Product and Solutions
2.13.4 Myriad Genetics Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Myriad Genetics Recent Developments and Future Plans
2.14 Panacea Pharmaceuticals
2.14.1 Panacea Pharmaceuticals Details
2.14.2 Panacea Pharmaceuticals Major Business
2.14.3 Panacea Pharmaceuticals Cancer Test Product and Solutions
2.14.4 Panacea Pharmaceuticals Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Panacea Pharmaceuticals Recent Developments and Future Plans
2.15 Qiagen
2.15.1 Qiagen Details
2.15.2 Qiagen Major Business
2.15.3 Qiagen Cancer Test Product and Solutions
2.15.4 Qiagen Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Qiagen Recent Developments and Future Plans
2.16 Siemens Heathcare Diagnostics
2.16.1 Siemens Heathcare Diagnostics Details
2.16.2 Siemens Heathcare Diagnostics Major Business
2.16.3 Siemens Heathcare Diagnostics Cancer Test Product and Solutions
2.16.4 Siemens Heathcare Diagnostics Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Siemens Heathcare Diagnostics Recent Developments and Future Plans
2.17 Roche
2.17.1 Roche Details
2.17.2 Roche Major Business
2.17.3 Roche Cancer Test Product and Solutions
2.17.4 Roche Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Roche Recent Developments and Future Plans
2.18 Roche(Ventana Medical Systems)
2.18.1 Roche(Ventana Medical Systems) Details
2.18.2 Roche(Ventana Medical Systems) Major Business
2.18.3 Roche(Ventana Medical Systems) Cancer Test Product and Solutions
2.18.4 Roche(Ventana Medical Systems) Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Roche(Ventana Medical Systems) Recent Developments and Future Plans
2.19 Trovagene
2.19.1 Trovagene Details
2.19.2 Trovagene Major Business
2.19.3 Trovagene Cancer Test Product and Solutions
2.19.4 Trovagene Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Trovagene Recent Developments and Future Plans
2.20 Vermillion
2.20.1 Vermillion Details
2.20.2 Vermillion Major Business
2.20.3 Vermillion Cancer Test Product and Solutions
2.20.4 Vermillion Cancer Test Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Vermillion Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Test Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Test Players Market Share
3.2.2 Top 10 Cancer Test Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Test Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Test Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Test Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cancer Test Revenue Market Share by Application (2016-2021)
5.2 Cancer Test Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Test Revenue by Type (2016-2026)
6.2 North America Cancer Test Revenue by Application (2016-2026)
6.3 North America Cancer Test Market Size by Country
6.3.1 North America Cancer Test Revenue by Country (2016-2026)
6.3.2 United States Cancer Test Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Test Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Test Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Test Revenue by Type (2016-2026)
7.2 Europe Cancer Test Revenue by Application (2016-2026)
7.3 Europe Cancer Test Market Size by Country
7.3.1 Europe Cancer Test Revenue by Country (2016-2026)
7.3.2 Germany Cancer Test Market Size and Forecast (2016-2026)
7.3.3 France Cancer Test Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Test Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Test Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Test Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Test Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Test Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Test Market Size by Region
8.3.1 Asia-Pacific Cancer Test Revenue by Region (2016-2026)
8.3.2 China Cancer Test Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Test Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Test Market Size and Forecast (2016-2026)
8.3.5 India Cancer Test Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Test Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Test Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Test Revenue by Type (2016-2026)
9.2 South America Cancer Test Revenue by Application (2016-2026)
9.3 South America Cancer Test Market Size by Country
9.3.1 South America Cancer Test Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Test Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Test Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Test Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Test Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Test Market Size by Country
10.3.1 Middle East & Africa Cancer Test Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Test Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Test Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Test Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cancer Test Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Test Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Test Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Test Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Test Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Cancer Test Product and Solutions
Table 9. Abbott Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Radient Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Radient Pharmaceuticals Major Business
Table 12. Radient Pharmaceuticals Cancer Test Product and Solutions
Table 13. Radient Pharmaceuticals Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. BD Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. BD Diagnostics Major Business
Table 16. BD Diagnostics Cancer Test Product and Solutions
Table 17. BD Diagnostics Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter Major Business
Table 20. Beckman Coulter Cancer Test Product and Solutions
Table 21. Beckman Coulter Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. BioCurex Corporate Information, Head Office, and Major Competitors
Table 23. BioCurex Major Business
Table 24. BioCurex Cancer Test Product and Solutions
Table 25. BioCurex Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. bioMerieux Corporate Information, Head Office, and Major Competitors
Table 27. bioMerieux Major Business
Table 28. bioMerieux Cancer Test Product and Solutions
Table 29. bioMerieux Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cepheid Corporate Information, Head Office, and Major Competitors
Table 31. Cepheid Major Business
Table 32. Cepheid Cancer Test Product and Solutions
Table 33. Cepheid Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. CytoCore Corporate Information, Head Office, and Major Competitors
Table 35. CytoCore Major Business
Table 36. CytoCore Cancer Test Product and Solutions
Table 37. CytoCore Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. DiagnoCure Corporate Information, Head Office, and Major Competitors
Table 39. DiagnoCure Major Business
Table 40. DiagnoCure Cancer Test Product and Solutions
Table 41. DiagnoCure Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Gen-Probe Corporate Information, Head Office, and Major Competitors
Table 43. Gen-Probe Major Business
Table 44. Gen-Probe Cancer Test Product and Solutions
Table 45. Gen-Probe Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 47. Genomic Health Major Business
Table 48. Genomic Health Cancer Test Product and Solutions
Table 49. Genomic Health Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. QIAGEN Marseille (Earlier Ipsogen) Corporate Information, Head Office, and Major Competitors
Table 51. QIAGEN Marseille (Earlier Ipsogen) Major Business
Table 52. QIAGEN Marseille (Earlier Ipsogen) Cancer Test Product and Solutions
Table 53. QIAGEN Marseille (Earlier Ipsogen) Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 55. Myriad Genetics Major Business
Table 56. Myriad Genetics Cancer Test Product and Solutions
Table 57. Myriad Genetics Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Panacea Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Panacea Pharmaceuticals Major Business
Table 60. Panacea Pharmaceuticals Cancer Test Product and Solutions
Table 61. Panacea Pharmaceuticals Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Qiagen Corporate Information, Head Office, and Major Competitors
Table 63. Qiagen Major Business
Table 64. Qiagen Cancer Test Product and Solutions
Table 65. Qiagen Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Siemens Heathcare Diagnostics Corporate Information, Head Office, and Major Competitors
Table 67. Siemens Heathcare Diagnostics Major Business
Table 68. Siemens Heathcare Diagnostics Cancer Test Product and Solutions
Table 69. Siemens Heathcare Diagnostics Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Roche Corporate Information, Head Office, and Major Competitors
Table 71. Roche Major Business
Table 72. Roche Cancer Test Product and Solutions
Table 73. Roche Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Roche(Ventana Medical Systems) Corporate Information, Head Office, and Major Competitors
Table 75. Roche(Ventana Medical Systems) Major Business
Table 76. Roche(Ventana Medical Systems) Cancer Test Product and Solutions
Table 77. Roche(Ventana Medical Systems) Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Trovagene Corporate Information, Head Office, and Major Competitors
Table 79. Trovagene Major Business
Table 80. Trovagene Cancer Test Product and Solutions
Table 81. Trovagene Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Vermillion Corporate Information, Head Office, and Major Competitors
Table 83. Vermillion Major Business
Table 84. Vermillion Cancer Test Product and Solutions
Table 85. Vermillion Cancer Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Cancer Test Revenue (USD Million) by Players (2019-2021)
Table 87. Global Cancer Test Revenue Share by Players (2019-2021)
Table 88. Breakdown of Cancer Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Cancer Test Players Head Office, Products and Services Provided
Table 90. Cancer Test Mergers & Acquisitions in the Past Five Years
Table 91. Cancer Test New Entrants and Expansion Plans
Table 92. Global Cancer Test Revenue (USD Million) by Type (2016-2021)
Table 93. Global Cancer Test Revenue Share by Type (2016-2021)
Table 94. Global Cancer Test Revenue Forecast by Type (2021-2026)
Table 95. Global Cancer Test Revenue by Application (2016-2021)
Table 96. Global Cancer Test Revenue Forecast by Application (2021-2026)
Table 97. North America Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Cancer Test Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Cancer Test Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Cancer Test Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Cancer Test Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Cancer Test Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Cancer Test Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Cancer Test Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Cancer Test Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Cancer Test Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Cancer Test Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Cancer Test Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Test Picture
Figure 2. Global Cancer Test Revenue Market Share by Type in 2020
Figure 3. Laboratory Tests
Figure 4. Genetic Tests
Figure 5. Imaging
Figure 6. Endoscopy
Figure 7. Cancer Test Revenue Market Share by Application in 2020
Figure 8. Bladder Cancer Test Picture
Figure 9. Breast Cancer Test Picture
Figure 10. Cervical Cancer Test Picture
Figure 11. Colorectal (Colon) Cancer Test Picture
Figure 12. Ovarian Cancer Test Picture
Figure 13. Prostate Cancer Test Picture
Figure 14. Liver Cancer Test Picture
Figure 15. Flow Cytometry Picture
Figure 16. Other Organ Specific Cancer Test Picture
Figure 17. Global Cancer Test Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 18. Global Cancer Test Revenue and Forecast (2016-2026) & (USD Million)
Figure 19. Global Cancer Test Revenue Market Share by Region (2016-2026)
Figure 20. Global Cancer Test Revenue Market Share by Region in 2020
Figure 21. North America Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Europe Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Asia-Pacific Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. South America Cancer Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Cancer Test Market Drivers
Figure 26. Cancer Test Market Restraints
Figure 27. Cancer Test Market Trends
Figure 28. Abbott Recent Developments and Future Plans
Figure 29. Radient Pharmaceuticals Recent Developments and Future Plans
Figure 30. BD Diagnostics Recent Developments and Future Plans
Figure 31. Beckman Coulter Recent Developments and Future Plans
Figure 32. BioCurex Recent Developments and Future Plans
Figure 33. bioMerieux Recent Developments and Future Plans
Figure 34. Cepheid Recent Developments and Future Plans
Figure 35. CytoCore Recent Developments and Future Plans
Figure 36. DiagnoCure Recent Developments and Future Plans
Figure 37. Gen-Probe Recent Developments and Future Plans
Figure 38. Genomic Health Recent Developments and Future Plans
Figure 39. QIAGEN Marseille (Earlier Ipsogen) Recent Developments and Future Plans
Figure 40. Myriad Genetics Recent Developments and Future Plans
Figure 41. Panacea Pharmaceuticals Recent Developments and Future Plans
Figure 42. Qiagen Recent Developments and Future Plans
Figure 43. Siemens Heathcare Diagnostics Recent Developments and Future Plans
Figure 44. Roche Recent Developments and Future Plans
Figure 45. Roche(Ventana Medical Systems) Recent Developments and Future Plans
Figure 46. Trovagene Recent Developments and Future Plans
Figure 47. Vermillion Recent Developments and Future Plans
Figure 49. Global Cancer Test Revenue Share by Players in 2020
Figure 50. Cancer Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 51. Global Top 3 Players Cancer Test Revenue Market Share in 2020
Figure 52. Global Top 10 Players Cancer Test Revenue Market Share in 2020
Figure 53. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 54. Global Cancer Test Revenue Share by Type in 2020
Figure 55. Global Cancer Test Market Share Forecast by Type (2021-2026)
Figure 56. Global Cancer Test Revenue Share by Application in 2020
Figure 57. Global Cancer Test Market Share Forecast by Application (2021-2026)
Figure 58. North America Cancer Test Sales Market Share by Type (2016-2026)
Figure 59. North America Cancer Test Sales Market Share by Application (2016-2026)
Figure 60. North America Cancer Test Revenue Market Share by Country (2016-2026)
Figure 61. United States Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Canada Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Mexico Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Europe Cancer Test Sales Market Share by Type (2016-2026)
Figure 65. Europe Cancer Test Sales Market Share by Application (2016-2026)
Figure 66. Europe Cancer Test Revenue Market Share by Country (2016-2026)
Figure 67. Germany Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. France Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. United Kingdom Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Russia Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Italy Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Asia-Pacific Cancer Test Sales Market Share by Type (2016-2026)
Figure 73. Asia-Pacific Cancer Test Sales Market Share by Application (2016-2026)
Figure 74. Asia-Pacific Cancer Test Revenue Market Share by Region (2016-2026)
Figure 75. China Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Japan Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Korea Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. India Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Southeast Asia Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Australia Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South America Cancer Test Sales Market Share by Type (2016-2026)
Figure 82. South America Cancer Test Sales Market Share by Application (2016-2026)
Figure 83. South America Cancer Test Revenue Market Share by Country (2016-2026)
Figure 84. Brazil Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Argentina Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Middle East and Africa Cancer Test Sales Market Share by Type (2016-2026)
Figure 87. Middle East and Africa Cancer Test Sales Market Share by Application (2016-2026)
Figure 88. Middle East and Africa Cancer Test Revenue Market Share by Country (2016-2026)
Figure 89. Turkey Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Saudi Arabia Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. UAE Cancer Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 92. Methodology
Figure 93. Research Process and Data Source
世界のがん検査市場規模・現状・予測（2021年-2027年） Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-…- 世界の子宮頸がん検査市場規模・現状・予測（2021年-2027年） Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA …
- 世界の子宮頸がん検査市場規模・現状・予測（2021年-2027年） Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA …
- 世界の子宮頸がん検査市場 2021：企業別、地域別、種類・用途別 The Cervical Cancer Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の腫瘍バイオマーカー検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…